Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The Company That’s Delivering Safe, Evidence-Based Psychedelic-Assisted Psychotherapies

(Click image to play podcast) Stockhouse investors who are dialed into the not-only nascent but now, pardon the pun, mushrooming psychedelics sector are likely familiar with a mental health and wellness company “centred on developing and supporting the safe, ev...
Dave Jackson | October 8, 2020 |

Psychedelic Leader to Advance Mental Health in 2021 with Growth of Clinics, Lab and Partnerships

(Image via Numinus Wellness Inc.) In 2020, Health Canada began allowing select patients to take psilocybin for relief of end-of-life-distress. This was followed by a proposed regulation revision that could allow doctors to prescribe both psilocybin and MDMA for t...
Stockhouse Editorial | January 14, 2021 |

What Do These Three Charts Have in Common?

Bob Moriarty of 321gold provides three charts for readers. Hint: That's what massive tops look like. Don't tell anyone else, I want to keep it a secret between you and me. Bob Moriarty founded 321gold.com , with his late wife, Barbara Moriarty, more...
Streetwise Reports | February 5, 2020 |

BioNTech, EXMceuticals, XPhyto - Covid-19 and legalizations offer potential

In recent months, the society around the globe has been going through a process of change of deceleration and standstill. Priorities have been redefined and implemented at record speeds in many places. Covid-19 serves as a catalyst for change for many people. The reasons can b...
Mario Hose | July 15, 2020 |

'Topline Beat, All Eyes on Potential M&A' by Health Technologies Firm

An update on the Canadian company, including its Q2/19 results and its next expected catalyst, is provided in a Haywood report. In an Aug. 23 research note, analyst Daniel Rosenberg reported that his firm Haywood increased its price target on WELL Health Technologies...
Streetwise Reports | August 28, 2019 |

Gold Explorer and Developer 'On Track to Repeat Atlantic Gold Success'

Observations and takeaways from a visit to the company's Bulgaria properties are given in a Haywood report. In an Aug. 21 research note, Haywood analyst Mick Carew reported that Velocity Minerals Ltd. (VLC:TSX.V; VLCJF:OTCQB) is "is on track to repeat Atlantic Gold ...
Streetwise Reports | August 30, 2019 |

Explorer Extends Copper-Gold Mineralization to Depth at Flagship B.C. Project

The key points regarding recent drill results and next steps are presented in a Haywood report. In a Sept. 4 research note, Haywood analyst Mick Carew reported that GT Gold Corp.'s (GTT:TSX.V) recent drill results from the Saddle North discovery at its Tatogga proje...
Streetwise Reports | September 20, 2019 |

Recent Drilling at Ecuador Project Returns 'Impressive' Results

The drill results are relayed and interpreted in a Haywood report. In a Sept. 27 research note, Haywood analyst Geordie Mark reported that Luminex Resources Corp. (LR:TSX.V; LUMIF:OTCMKTS) continues to show continuity of high-grade epithermal gold mineralization at ...
Streetwise Reports | October 4, 2019 |

Protalix Shares Trade up 70% Upon Release of Phase 3 Fabry Disease Data

Shares of Protalix Biotherapeutics skyrocketed today on much higher than average volume as the firm announced positive 12-month interim data from its BRIDGE Phase 3 open label switch-over study of pegunigalsidase alfa (PRX-102) for the treatment of Fabry disease. Earl...
Streetwise Reports | October 18, 2019 |

Seachange in Mexico on Cannabis Could Benefit This Small Cap

Technical analyst Clive Maund highlights a small-cap that may be poised to benefit from the recent Mexican Supreme Court decision on cannabis. Although there is little net change in Captiva Verde Land Corp. (PWR:CSE) since we last looked at it just over a month ago...
Streetwise Reports | November 14, 2019 |
1 2 3 4 5 6 7 8 9 10 ...